NEUROFIBROMATOSIS, TYPE 1-LIKE SYNDROME

Known as: Legius syndrome, NFLS, Neurofibromatosis Type 1-Like Syndrome 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1978-2017
02419782017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Legius syndrome (Online Mendelian Inheritance in Man no. 611431) or neurofibromatosis type 1 (NF1)-like syndrome was first… (More)
  • figure 2
  • figure 1
  • figure 3
Is this relevant?
2012
2012
OBJECTIVES To measure the accuracy of anamnestic features collected during clinical history for the diagnosis of nocturnal… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
CONTEXT Autosomal dominant inactivating sprouty-related EVH1 domain-containing protein 1 (SPRED1) mutations have recently been… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2009
2009
OBJECTIVE Germline loss-of-function mutations in the SPRED1 gene have recently been identified in patients fulfilling the… (More)
  • table 1
Is this relevant?
2009
2009
THE STUDY BY MESSIAEN AND COLLEAGUES 1 IN THIS issue of JAMA provides a significant advance in understanding the clinical… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
OBJECTIVES The aim of this study was to assess and validate 2-dimensional (2D) strain for the detection of ischemia during… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
BACKGROUND Nocturnal frontal lobe seizures (NFLS) show one or all of the following semeiological patterns: (1) paroxysmal… (More)
Is this relevant?
2004
2004
Neurofilament proteins (NFP) are intermediate filaments found in the neuronal cytoskeleton. They are highly phosphorylated, a… (More)
Is this relevant?
2001
2001
OBJECTIVES The present study examined the ability of real-time myocardial contrast echocardiography (MCE) to delineate… (More)
Is this relevant?
2001
2001
BACKGROUND Controversy continues as to whether adenosine or dobutamine is the superior pharmacological stress agent for… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?